Eunkyung Kauh - Concepedia

Author

Eunkyung Kauh

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

E A Kauh, E Kauh, E. A. Kauh, Eunkyung A. Kauh, Eunkyung Kauh

Publications

640

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Thomas Jefferson University Profil Institute for Clinical Research Precision Research Institute

About

Eunkyung Kauh is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, natural sciences, and dna replication.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	267
2	Natural Sciences	2	2	169
3	Cell Biology	2	2	169
4	Diabetes	2	2	37
5	Public Health	1	1	61

Eunkyung Kauh

Publications

622

Citations

H-Index

Page 1

	Year	Citations
Cloning of Full-length Elastin cDNAs from a Human Skin Fibroblast Recombinant cDNA Library: Further Elucidation of Alternative Splicing Utilizing Exon-specific Oligonucleotides Michael Fazio, David R. Olsen, Eunkyung Kauh, Journal of Investigative Dermatology Exon-specific OligonucleotidesFurther ElucidationNatural SciencesOligonucleotideMolecular Biology	1988	101
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging Arian Mashhood, Radha Railkar, Takeshi Yokoo, Journal of Magnetic Resonance Imaging	2012	74
Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals Eunkyung Kauh, Lori Mixson, Marie‐Pierre Malice, European Journal of Endocrinology	2011	70
SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I. Eunkyung Kauh, Mary‐Ann Bjornsti Proceedings of the National Academy of Sciences Sct1 MutantsApoptosisMolecular BiologyCell DeathYeast Cells	1995	68
Camptothecin Sensitivity Is Mediated by the Pleiotropic Drug Resistance Network in Yeast Robert J. D. Reid, Eunkyung Kauh, Mary‐Ann Bjornsti Journal of Biological Chemistry	1997	67
Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis Dionysios Neofytos, Radha Railkar, Kathleen M. Mullane, PLoS ONE Circulating Fungal BiomarkersDiagnostic MycologyFungal Cell BiologyImmunodeficienciesPathology	2015	61
Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin Daniel Tatosian, Ying Guo, Andrea Schaeffer, Diabetes Therapy	2013	47
Pharmacokinetic and Pharmacodynamic Effects of Multiple-dose Administration of Omarigliptin, a Once-weekly Dipeptidyl Peptidase-4 Inhibitor, in Obese Participants With and Without Type 2 Diabetes Mellitus Carol Addy, Daniel Tatosian, Xiaoli S. Glasgow, Clinical Therapeutics ObesityMetabolic SyndromeWithout Type 2MedicineMultiple-dose Administration	2016	27
Short‐term metabolic effects of prednisone administration in healthy subjects Eunkyung Kauh, Lori Mixson, Sudha S. Shankar, Diabetes Obesity and Metabolism	2011	25
Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once‐weekly dipeptidyl peptidase‐4 inhibitor, in healthy Japanese men Saori Tsuchiya, Evan Friedman, Carol Addy, Journal of Diabetes Investigation	2016	25

Page 1